The Efficacy of tadarafili for Bladder outlet obstruction and storage function: prospective urodynamic study
Phase 4
Recruiting
- Conditions
- benign prostatic hyperplasia
- Registration Number
- JPRN-UMIN000017925
- Lead Sponsor
- Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Patients were excluded if they received oral treatment with alpha1-blockers, anticholinergic agents, antidepressants, 5ARI, anti-anxiety agents, or sex hormonal agents; had neurogenic bladder dysfunction, bladder calculi, or active urinary tract infection; had severe cardiac disease, renal dysfunction (serum-creatinine >2 mg/dL), hepatic dysfunction (aspartate aminotransferase and alanine aminotransferase more than twice the normal value).
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of bladder outlet obstruction and storage function
- Secondary Outcome Measures
Name Time Method The change of subjective parameters